Bristol Myers Squibb Welcomes Mayada Al-Ahmad as General Manager for Saudi Arabia and Gulf Countries

On June 1, 2026, Bristol Myers Squibb (BMS), a prominent global biopharmaceutical firm, confirmed the appointment of Mayada Al-Ahmad as General Manager for Saudi Arabia and the Gulf region. This critical role encompasses leadership over the affiliate which spans various countries including Saudi Arabia, the UAE, Kuwait, Qatar, Oman, Bahrain, and Jordan. The company's mission is to deliver transformative medicines to patients in these areas, a goal that aligns with health transformation priorities in the region.

Michelle Calope, Senior Vice President and Head of Intercontinental Markets at BMS, expressed confidence in Mayada’s capabilities. She noted that Al-Ahmad's extensive understanding of the Saudi and Gulf markets, coupled with her robust regional network, positions her favorably to lead the affiliate through its next growth phase. Mayada's leadership is expected to be vital in advancing BMS's mission and aligning efforts with the national health initiatives across the region.

With over two decades of experience in the pharmaceutical industry, Mayada brings a wealth of knowledge and expertise. Her roles have included commercial, strategic, and country management responsibilities across diverse geographies, including the Middle East, Africa, and even Turkey, Russia, and intercontinental markets. Notably, Mayada has significant expertise in therapeutic areas such as oncology, hematology, cardiovascular, neuroscience, and diabetes. She has consistently demonstrated her ability to drive performance and build strong, patient-centered teams in various challenging market scenarios.

In her own words, Mayada Al-Ahmad stated, “I am honored and enthusiastic to step into this pivotal role, leading Bristol Myers Squibb's efforts across Saudi Arabia and the Gulf Countries. It is a privilege to contribute to our vital mission of delivering innovative medicines and making a meaningful difference in patients' lives throughout this dynamic region. I look forward to working closely with our talented team and valued partners to further our commitment to health and scientific advancement.”

Bristol Myers Squibb remains dedicated to transforming patients' lives through scientific innovation. The company aims to discover, develop, and deliver groundbreaking medicines that enable patients to overcome serious health conditions. Through bold scientific endeavors, BMS seeks to redefine what is achievable in medicine and enhance the lives of those they serve.

For more information, visit BMS.com and stay connected via various social media platforms including LinkedIn, X, YouTube, Facebook, and Instagram. The appointment of Mayada Al-Ahmad is not just a progression in her career; it signals a promising future for BMS in addressing and fulfilling the healthcare needs of the Gulf region. This transformation will cater to the evolving landscape of health and wellness in a region known for its rapid development and growing demand for innovative medical solutions.